XAF1: A Potential Drug Target and Biomarker (G54739)

Target Name: XAF1

NCBI ID: G54739

XAF1

XAF1: A Potential Drug Target and Biomarker

XAF1, also known as SIRT1, is a gene that encodes a protein with nuclear overlay, which is involved in various cellular processes. Research has shown that XAF1 plays a crucial role in the detoxification of xenobiotics, which are harmful substances that can cause cancer in humans. Therefore, XAF1 has potential as a drug target or biomarker for various diseases.

XAF1 functions as a antioxidant by neutralizing free radicals, which are highly reactive molecules that can cause damage to cells and contribute to the development of diseases. free radicals)

XAF1 has been shown to have a direct impact on the detoxification of xenobiotics, such as polycyclic aromatic hydrocarbons (PAHs) and polycyclic nitrogen compounds (PCNs), which are known to cause cancer in humans. Studies have shown that XAF1 can reduce the levels of PAHs and PCNs in cells, indicating that it has a positive effect on the detoxification process.

In addition to its role in detoxification, XAF1 has also been shown to play a role in cellular signaling. XAF1 has been shown to interact with various signaling pathways, including the TGF-β pathway, which is involved in cell growth and survival. Furthermore, XAF1 has been shown to play a role in the regulation of cellular apoptosis, which is the process by which cells die naturally in response to various stimuli.

XAF1 has also been shown to have a direct impact on the expression of genes involved in cell growth and apoptosis. For example, studies have shown that XAF1 can inhibit the expression of genes involved in cell cycle progression and apoptosis, such as p21 and p53. This suggests that XAF1 may have a negative impact on the growth and survival of cancer cells.

Despite its potential as a drug target or biomarker, there are also potential drawbacks to the study of XAF1. One of the main challenges is the difficulty of studying the function of XAF1 in live organisms, as the protein is expressed in the nuclear overlay and is not typically expressed in the cytoplasm. Additionally, the role of XAF1 in various diseases is not yet fully understood, and more research is needed to determine its true potential as a drug target or biomarker.

In conclusion, XAF1 is a gene that encodes a protein with nuclear overlay that is involved in various cellular processes. Studies have shown that XAF1 plays a crucial role in the detoxification of xenobiotics and has been shown to interact with various signaling pathways. Additionally, XAF1 has been shown to have a direct impact on the expression of genes involved in cell growth and apoptosis. While the potential of XAF1 as a drug target or biomarker is an exciting area of research, more research is needed to fully understand its function and potential applications in medicine.

Protein Name: XIAP Associated Factor 1

Functions: Seems to function as a negative regulator of members of the IAP (inhibitor of apoptosis protein) family. Inhibits anti-caspase activity of BIRC4. Induces cleavage and inactivation of BIRC4 independent of caspase activation. Mediates TNF-alpha-induced apoptosis and is involved in apoptosis in trophoblast cells. May inhibit BIRC4 indirectly by activating the mitochondrial apoptosis pathway. After translocation to mitochondria, promotes translocation of BAX to mitochondria and cytochrome c release from mitochondria. Seems to promote the redistribution of BIRC4 from the cytoplasm to the nucleus, probably independent of BIRC4 inactivation which seems to occur in the cytoplasm. The BIRC4-XAF1 complex mediates down-regulation of BIRC5/survivin; the process requires the E3 ligase activity of BIRC4. Seems to be involved in cellular sensitivity to the proapoptotic actions of TRAIL. May be a tumor suppressor by mediating apoptosis resistance of cancer cells

The "XAF1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about XAF1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets